These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34202213)

  • 21. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.
    Piras V; Ferreli C; Atzori L; Pinna G; Pilloni L
    Pathologica; 2020 Jun; 112(2):105-109. PubMed ID: 32760054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The many faces of Atypical fibroxanthoma.
    Agaimy A
    Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Updates on Classification and Management.
    Soleymani T; Aasi SZ; Novoa R; Hollmig ST
    Dermatol Clin; 2019 Jul; 37(3):253-259. PubMed ID: 31084719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the lymphatic vessel architecture of atypical fibroxanthoma and pleomorphic dermal sarcoma.
    Zschoche C; Hamsch C; Kutzner H; Mentzel T; Werchau S; Enk A; Hartschuh W; Hadaschik E; Toberer F
    J Am Acad Dermatol; 2014 Oct; 71(4):842-5. PubMed ID: 25219715
    [No Abstract]   [Full Text] [Related]  

  • 25. Atypical fibroxanthoma and pleomorphic dermal sarcoma - gene expression analysis compared with undifferentiated cutaneous squamous cell carcinoma.
    Anders IM; Schimmelpfennig C; Wiedemann K; Löffler D; Kämpf C; Blumert C; Reiche K; Kunz M; Anderegg U; Simon JC; Ziemer M
    J Dtsch Dermatol Ges; 2023 May; 21(5):482-491. PubMed ID: 37035902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide methylation profiling and copy number analysis in atypical fibroxanthomas and pleomorphic dermal sarcomas indicate a similar molecular phenotype.
    Koelsche C; Stichel D; Griewank KG; Schrimpf D; Reuss DE; Bewerunge-Hudler M; Vokuhl C; Dinjens WNM; Petersen I; Mittelbronn M; Cuevas-Bourdier A; Buslei R; Pfister SM; Flucke U; Mechtersheimer G; Mentzel T; von Deimling A
    Clin Sarcoma Res; 2019; 9():2. PubMed ID: 30809375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pleomorphic dermal sarcoma: Clinicopathological features and outcomes from a 5-year tertiary referral centre experience.
    Logan IT; Vroobel KM; le Grange F; Perrett CM
    Cancer Rep (Hoboken); 2022 Nov; 5(11):e1583. PubMed ID: 34766474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical Characteristics of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: A Systematic Review and Meta-Analysis.
    Ørholt M; Abebe K; Aaberg F; Rasmussen LE; Daugaard S; Loya AC; Herly M; Vester-Glowinski PV
    Am J Dermatopathol; 2022 Dec; 44(12):913-920. PubMed ID: 36395448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrochlorothiazide and increased risk of atypical fibroxanthoma and pleomorphic dermal sarcoma.
    Kuntz T; Grimm A; Hofmann SC; Michalowitz AL; Schaller J; Hellmich M; Assaf C; Oellig F; Kreuter A
    J Dtsch Dermatol Ges; 2024 Apr; 22(4):513-519. PubMed ID: 38483049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical fibroxanthoma with pseudoangiomatous features: a histological and immunohistochemical mimic of cutaneous angiosarcoma.
    Thum C; Husain EA; Mulholland K; Hornick JL; Brenn T
    Ann Diagn Pathol; 2013 Dec; 17(6):502-7. PubMed ID: 24080496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Usefulness of Ultrasonography for Supporting the Differentiation, Diagnosis, and Treatment of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma.
    Crisan D; Schneider LA; Scharffetter-Kochanek K; Bernhard L; Crisan M; Wortsman X
    J Ultrasound Med; 2024 Aug; 43(8):1563-1572. PubMed ID: 38703399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rare Intravascular Involvement of Pleomorphic Dermal Sarcoma Seen During Mohs Micrographic Surgery.
    Carrasco Mendoza CA; Castillo JR
    Perm J; 2024 Dec; 28(4):95-99. PubMed ID: 39262213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical fibroxanthoma: An analysis of 105 tumors.
    Bitel A; Schönlebe J; Krönert C; Wollina U
    Dermatol Ther; 2020 Nov; 33(6):e13962. PubMed ID: 32618393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S; Mar N; McCalmont TH
    Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical fibroxanthoma and pleomorphic dermal sarcoma: Local recurrence and metastasis in a nationwide population-based cohort of 1118 patients.
    Ørholt M; Abebe K; Rasmussen LE; Aaberg FL; Lindskov LJ; Schmidt G; Wagenblast AL; Petersen MM; Loya AC; Daugaard S; Herly M; Jensen DH; Vester-Glowinski P
    J Am Acad Dermatol; 2023 Dec; 89(6):1177-1184. PubMed ID: 37634740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
    Lin DI; Hemmerich A; Edgerly C; Duncan D; Severson EA; Huang RSP; Ramkissoon SH; Connor YD; Shea M; Hecht JL; Ali SM; Vergilio JA; Ross JS; Elvin JA
    Gynecol Oncol; 2020 May; 157(2):357-366. PubMed ID: 32156473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sarcoma-like tumor of head and neck skin.
    Nonaka D; Bishop PW
    Am J Surg Pathol; 2014 Jul; 38(7):956-65. PubMed ID: 24705313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation Between Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Histopathologic Features and Review of the Literature.
    Iglesias-Pena N; Martínez-Campayo N; López-Solache L
    Actas Dermosifiliogr (Engl Ed); 2021 May; 112(5):392-405. PubMed ID: 33301761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma.
    Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic landscape of gliosarcoma: distinguishing features and targetable alterations.
    Zaki MM; Mashouf LA; Woodward E; Langat P; Gupta S; Dunn IF; Wen PY; Nahed BV; Bi WL
    Sci Rep; 2021 Sep; 11(1):18009. PubMed ID: 34504233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.